Olprinone
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | IV |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
106730-54-5 |
| PubChem (CID) | 4593 |
| ChemSpider |
4432 |
| UNII |
4Y8BMI9YGC |
| Chemical and physical data | |
| Formula | C14H10N4O |
| Molar mass | 250.25 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Olprinone (INN) is a cardiotonic agent.[1] It has been marketed in Japan since 1996.[2]
References
- ↑ Uemura Y, Tanaka S, Ida S, Yuzuriha T (December 1993). "Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs". J. Pharm. Pharmacol. 45 (12): 1077–81. doi:10.1111/j.2042-7158.1993.tb07184.x. PMID 7908977.
- ↑ (English)"Coretec Injection 5 mg" (PDF). Eisai Co. April 2005. Retrieved 2008-06-26.
This article is issued from Wikipedia - version of the 11/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
